KEGG   ORTHOLOGY: K04503
Entry
K04503                      KO                                     

Symbol
CCND1
Name
G1/S-specific cyclin-D1
Pathway
map01522  Endocrine resistance
map04068  FoxO signaling pathway
map04110  Cell cycle
map04115  p53 signaling pathway
map04151  PI3K-Akt signaling pathway
map04152  AMPK signaling pathway
map04218  Cellular senescence
map04310  Wnt signaling pathway
map04340  Hedgehog signaling pathway
map04371  Apelin signaling pathway
map04390  Hippo signaling pathway
map04510  Focal adhesion
map04530  Tight junction
map04630  JAK-STAT signaling pathway
map04917  Prolactin signaling pathway
map04919  Thyroid hormone signaling pathway
map04921  Oxytocin signaling pathway
map04933  AGE-RAGE signaling pathway in diabetic complications
map04934  Cushing syndrome
map04936  Alcoholic liver disease
map05160  Hepatitis C
map05162  Measles
map05163  Human cytomegalovirus infection
map05165  Human papillomavirus infection
map05166  Human T-cell leukemia virus 1 infection
map05167  Kaposi sarcoma-associated herpesvirus infection
map05169  Epstein-Barr virus infection
map05200  Pathways in cancer
map05203  Viral carcinogenesis
map05205  Proteoglycans in cancer
map05206  MicroRNAs in cancer
map05207  Chemical carcinogenesis - receptor activation
map05210  Colorectal cancer
map05212  Pancreatic cancer
map05213  Endometrial cancer
map05214  Glioma
map05215  Prostate cancer
map05216  Thyroid cancer
map05218  Melanoma
map05219  Bladder cancer
map05220  Chronic myeloid leukemia
map05221  Acute myeloid leukemia
map05222  Small cell lung cancer
map05223  Non-small cell lung cancer
map05224  Breast cancer
map05225  Hepatocellular carcinoma
map05226  Gastric cancer
map05416  Viral myocarditis
Disease
H00006  Hairy cell leukemia
H00010  Multiple myeloma
H00016  Oral cancer
H00017  Esophageal cancer
H00031  Breast cancer
H00055  Laryngeal cancer
H00559  von Hippel-Lindau syndrome
H01464  Mantle cell lymphoma
Brite
KEGG Orthology (KO) [BR:ko00001]
 09130 Environmental Information Processing
  09132 Signal transduction
   04310 Wnt signaling pathway
    K04503  CCND1; G1/S-specific cyclin-D1
   04340 Hedgehog signaling pathway
    K04503  CCND1; G1/S-specific cyclin-D1
   04390 Hippo signaling pathway
    K04503  CCND1; G1/S-specific cyclin-D1
   04371 Apelin signaling pathway
    K04503  CCND1; G1/S-specific cyclin-D1
   04630 JAK-STAT signaling pathway
    K04503  CCND1; G1/S-specific cyclin-D1
   04068 FoxO signaling pathway
    K04503  CCND1; G1/S-specific cyclin-D1
   04151 PI3K-Akt signaling pathway
    K04503  CCND1; G1/S-specific cyclin-D1
   04152 AMPK signaling pathway
    K04503  CCND1; G1/S-specific cyclin-D1
 09140 Cellular Processes
  09143 Cell growth and death
   04110 Cell cycle
    K04503  CCND1; G1/S-specific cyclin-D1
   04115 p53 signaling pathway
    K04503  CCND1; G1/S-specific cyclin-D1
   04218 Cellular senescence
    K04503  CCND1; G1/S-specific cyclin-D1
  09144 Cellular community - eukaryotes
   04510 Focal adhesion
    K04503  CCND1; G1/S-specific cyclin-D1
   04530 Tight junction
    K04503  CCND1; G1/S-specific cyclin-D1
 09150 Organismal Systems
  09152 Endocrine system
   04917 Prolactin signaling pathway
    K04503  CCND1; G1/S-specific cyclin-D1
   04921 Oxytocin signaling pathway
    K04503  CCND1; G1/S-specific cyclin-D1
   04919 Thyroid hormone signaling pathway
    K04503  CCND1; G1/S-specific cyclin-D1
 09160 Human Diseases
  09161 Cancer: overview
   05200 Pathways in cancer
    K04503  CCND1; G1/S-specific cyclin-D1
   05206 MicroRNAs in cancer
    K04503  CCND1; G1/S-specific cyclin-D1
   05205 Proteoglycans in cancer
    K04503  CCND1; G1/S-specific cyclin-D1
   05207 Chemical carcinogenesis - receptor activation
    K04503  CCND1; G1/S-specific cyclin-D1
   05203 Viral carcinogenesis
    K04503  CCND1; G1/S-specific cyclin-D1
  09162 Cancer: specific types
   05210 Colorectal cancer
    K04503  CCND1; G1/S-specific cyclin-D1
   05212 Pancreatic cancer
    K04503  CCND1; G1/S-specific cyclin-D1
   05225 Hepatocellular carcinoma
    K04503  CCND1; G1/S-specific cyclin-D1
   05226 Gastric cancer
    K04503  CCND1; G1/S-specific cyclin-D1
   05214 Glioma
    K04503  CCND1; G1/S-specific cyclin-D1
   05216 Thyroid cancer
    K04503  CCND1; G1/S-specific cyclin-D1
   05221 Acute myeloid leukemia
    K04503  CCND1; G1/S-specific cyclin-D1
   05220 Chronic myeloid leukemia
    K04503  CCND1; G1/S-specific cyclin-D1
   05218 Melanoma
    K04503  CCND1; G1/S-specific cyclin-D1
   05219 Bladder cancer
    K04503  CCND1; G1/S-specific cyclin-D1
   05215 Prostate cancer
    K04503  CCND1; G1/S-specific cyclin-D1
   05213 Endometrial cancer
    K04503  CCND1; G1/S-specific cyclin-D1
   05224 Breast cancer
    K04503  CCND1; G1/S-specific cyclin-D1
   05222 Small cell lung cancer
    K04503  CCND1; G1/S-specific cyclin-D1
   05223 Non-small cell lung cancer
    K04503  CCND1; G1/S-specific cyclin-D1
  09172 Infectious disease: viral
   05166 Human T-cell leukemia virus 1 infection
    K04503  CCND1; G1/S-specific cyclin-D1
   05160 Hepatitis C
    K04503  CCND1; G1/S-specific cyclin-D1
   05162 Measles
    K04503  CCND1; G1/S-specific cyclin-D1
   05163 Human cytomegalovirus infection
    K04503  CCND1; G1/S-specific cyclin-D1
   05167 Kaposi sarcoma-associated herpesvirus infection
    K04503  CCND1; G1/S-specific cyclin-D1
   05169 Epstein-Barr virus infection
    K04503  CCND1; G1/S-specific cyclin-D1
   05165 Human papillomavirus infection
    K04503  CCND1; G1/S-specific cyclin-D1
  09166 Cardiovascular disease
   05416 Viral myocarditis
    K04503  CCND1; G1/S-specific cyclin-D1
  09167 Endocrine and metabolic disease
   04936 Alcoholic liver disease
    K04503  CCND1; G1/S-specific cyclin-D1
   04933 AGE-RAGE signaling pathway in diabetic complications
    K04503  CCND1; G1/S-specific cyclin-D1
   04934 Cushing syndrome
    K04503  CCND1; G1/S-specific cyclin-D1
  09176 Drug resistance: antineoplastic
   01522 Endocrine resistance
    K04503  CCND1; G1/S-specific cyclin-D1
Genes
HSA: 595(CCND1)
PTR: 747442(CCND1)
PPS: 100995605(CCND1)
GGO: 101130447(CCND1)
PON: 100171625(CCND1)
NLE: 100605736(CCND1)
MCC: 574320(CCND1)
MCF: 102135329(CCND1)
CSAB: 103246489(CCND1)
CATY: 105577306(CCND1)
PANU: 101019923(CCND1)
RRO: 104677168(CCND1)
RBB: 108538745(CCND1)
TFN: 117081518(CCND1)
PTEH: 111522272(CCND1)
CJC: 100399312
SBQ: 101047858(CCND1)
MMUR: 105867511(CCND1)
MMU: 12443(Ccnd1)
MCAL: 110298189(Ccnd1)
MPAH: 110322378(Ccnd1)
RNO: 58919(Ccnd1)
MCOC: 116103285(Ccnd1)
MUN: 110546940(Ccnd1)
CGE: 100689063(Ccnd1)
PLEU: 114694498(Ccnd1)
NGI: 103751498(Ccnd1)
HGL: 101712621(Ccnd1)
CCAN: 109696351(Ccnd1)
TUP: 102490651(CCND1)
CFA: 449028(CCND1)
VVP: 112924157(CCND1)
VLG: 121501724(CCND1)
AML: 100469787(CCND1)
UMR: 103671139(CCND1)
UAH: 113243982(CCND1)
ORO: 101371532(CCND1)
ELK: 111149458
MPUF: 101670844(CCND1)
EJU: 114220310(CCND1)
MLX: 118016166(CCND1)
FCA: 100037407(CCND1)
PYU: 121023852(CCND1)
PTG: 102959906(CCND1)
PPAD: 109246902(CCND1)
AJU: 106971167(CCND1)
HHV: 120233874(CCND1)
BTA: 524530(CCND1)
BOM: 102270546(CCND1)
BIU: 109554439(CCND1)
BBUB: 102411133(CCND1)
CHX: 102169650(CCND1)
OAS: 100144763(CCND1)
ODA: 120874144(CCND1)
CCAD: 122430666(CCND1)
SSC: 100738589(CCND1)
CFR: 102518309(CCND1)
CBAI: 105070367(CCND1)
CDK: 105104393(CCND1)
BACU: 103013404(CCND1)
LVE: 103090612(CCND1)
OOR: 101273294(CCND1)
DLE: 111183632(CCND1)
PCAD: 102996914(CCND1)
ECB: 102149114(CCND1)
EAI: 106844248(CCND1)
MYB: 102263484(CCND1)
MYD: 102759793(CCND1)
MMYO: 118665181(CCND1)
MNA: 107537434(CCND1)
HAI: 109389297(CCND1)
DRO: 112317273(CCND1)
SHON: 118998396(CCND1)
AJM: 119041888(CCND1)
MMF: 118628257(CCND1)
PALE: 102885330(CCND1)
PGIG: 120584714(CCND1)
RAY: 107503391(CCND1)
MJV: 108388480(CCND1)
TOD: 119246910 119249876(CCND1)
LAV: 100669703(CCND1)
TMU: 101359745
MDO: 100013257(CCND1)
SHR: 100917462(CCND1)
PCW: 110197171(CCND1)
OAA: 100075081(CCND1)
GGA: 396341(CCND1)
PCOC: 116229085(CCND1)
MGP: 100539759(CCND1)
CJO: 107314428(CCND1)
NMEL: 110400907(CCND1)
APLA: 101800639(CCND1)
ACYG: 106044779(CCND1)
TGU: 100231612(CCND1)
LSR: 110469631(CCND1)
SCAN: 103822217(CCND1)
PMOA: 120509851(CCND1)
GFR: 102042858(CCND1)
FAB: 101807319(CCND1)
PHI: 102099659(CCND1)
PMAJ: 107205992(CCND1)
CCAE: 111930656(CCND1)
CCW: 104697629(CCND1)
ETL: 114067926(CCND1)
FPG: 101914937(CCND1)
FCH: 102053036(CCND1)
CLV: 102086245(CCND1)
EGZ: 104124693(CCND1)
NNI: 104009408(CCND1)
ACUN: 113481227(CCND1)
PADL: 103925769(CCND1)
AAM: 106498229(CCND1)
NPD: 112943487(CCND1)
ASN: 102378816(CCND1)
AMJ: 102563714(CCND1)
CPOO: 109321196(CCND1)
GGN: 109298996(CCND1)
PSS: 102457993(CCND1)
CMY: 102947923(CCND1)
CPIC: 101943958(CCND1)
TST: 117877043(CCND1)
CABI: 116819583(CCND1)
ACS: 100563772(ccnd1)
PVT: 110073542(CCND1)
PBI: 103066913(CCND1)
PMUR: 107285821(CCND1)
TSR: 106546690(CCND1)
PGUT: 117665432(CCND1)
PMUA: 114596879(CCND1)
ZVI: 118085960(CCND1)
GJA: 107121511(CCND1)
XLA: 379161(ccnd1.S) 379937(ccnd1.L) 447541 447748(ccndx.L)
XTR: 448045(ccnd1) 548862(ccndx)
NPR: 108785450(CCND1) 108793412
DRE: 30222(ccnd1)
CCAR: 109093191(ccnd1)
IPU: 108271119(ccnd1)
PHYP: 113528462 113536429(ccnd1)
AMEX: 103031956(ccnd1)
EEE: 113578962(ccnd1) 113588422
TRU: 101061278(ccnd1)
LCO: 104937240(ccnd1) 104939589
NCC: 104950786(ccnd1) 104967413
CGOB: 115004643(ccnd1) 115009127
ELY: 117257798(ccnd1) 117261946
SLUC: 116040204 116041081(ccnd1)
ECRA: 117946450(ccnd1) 117948766
PFLV: 114552928(ccnd1) 114560618
MSAM: 119890260(ccnd1) 119894289
CUD: 121512170(ccnd1) 121514619
MZE: 101467298 101485361(ccnd1)
ONL: 100691051(ccnd1) 100691373
OAU: 116331023 116332748(ccnd1)
OLA: 101169672(ccnd1)
OML: 112141930(ccnd1)
XMA: 102233074(ccnd1)
XCO: 114143123(ccnd1)
XHE: 116719094(ccnd1)
PRET: 103462287(ccnd1)
CVG: 107096221(ccnd1)
CTUL: 119795187(ccnd1)
NFU: 107374449(ccnd1)
KMR: 108237918(ccnd1)
ALIM: 106510985(ccnd1)
AOCE: 111576239(ccnd1)
CSEM: 103379080 103379853(ccnd1)
POV: 109625110(ccnd1) 109642994
SDU: 111221119(ccnd1) 111234824
XGL: 120792411(ccnd1) 120793380(zgc:158868)
BPEC: 110169262(ccnd1) 110174870
MALB: 109967859(ccnd1)
ELS: 105017289(ccnd1) 105018279
SFM: 108940463 108941209(ccnd1)
PKI: 111851863
LOC: 102687804(ccnd1)
ARUT: 117432035(ccnd1) 117435119
LCM: 102361167(CCND1) 102367471
TCA: 660655
HAME: 121864115
EAF: 111700425
FCY: FRACYDRAFT_140762(dsCyc9b)
 » show all
Reference
PMID:1826542
  Authors
Motokura T, Bloom T, Kim HG, Juppner H, Ruderman JV, Kronenberg HM, Arnold A
  Title
A novel cyclin encoded by a bcl1-linked candidate oncogene.
  Journal
Nature 350:512-5 (1991)
DOI:10.1038/350512a0
  Sequence
[hsa:595]
LinkDB

KEGG   ORTHOLOGY: K10151
Entry
K10151                      KO                                     

Symbol
CCND2
Name
G1/S-specific cyclin-D2
Pathway
map04068  FoxO signaling pathway
map04110  Cell cycle
map04115  p53 signaling pathway
map04151  PI3K-Akt signaling pathway
map04218  Cellular senescence
map04310  Wnt signaling pathway
map04340  Hedgehog signaling pathway
map04390  Hippo signaling pathway
map04510  Focal adhesion
map04630  JAK-STAT signaling pathway
map04917  Prolactin signaling pathway
map05162  Measles
map05165  Human papillomavirus infection
map05166  Human T-cell leukemia virus 1 infection
map05169  Epstein-Barr virus infection
map05200  Pathways in cancer
map05202  Transcriptional misregulation in cancer
map05203  Viral carcinogenesis
map05206  MicroRNAs in cancer
Disease
H00023  Testicular cancer
H01885  Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome
Brite
KEGG Orthology (KO) [BR:ko00001]
 09130 Environmental Information Processing
  09132 Signal transduction
   04310 Wnt signaling pathway
    K10151  CCND2; G1/S-specific cyclin-D2
   04340 Hedgehog signaling pathway
    K10151  CCND2; G1/S-specific cyclin-D2
   04390 Hippo signaling pathway
    K10151  CCND2; G1/S-specific cyclin-D2
   04630 JAK-STAT signaling pathway
    K10151  CCND2; G1/S-specific cyclin-D2
   04068 FoxO signaling pathway
    K10151  CCND2; G1/S-specific cyclin-D2
   04151 PI3K-Akt signaling pathway
    K10151  CCND2; G1/S-specific cyclin-D2
 09140 Cellular Processes
  09143 Cell growth and death
   04110 Cell cycle
    K10151  CCND2; G1/S-specific cyclin-D2
   04115 p53 signaling pathway
    K10151  CCND2; G1/S-specific cyclin-D2
   04218 Cellular senescence
    K10151  CCND2; G1/S-specific cyclin-D2
  09144 Cellular community - eukaryotes
   04510 Focal adhesion
    K10151  CCND2; G1/S-specific cyclin-D2
 09150 Organismal Systems
  09152 Endocrine system
   04917 Prolactin signaling pathway
    K10151  CCND2; G1/S-specific cyclin-D2
 09160 Human Diseases
  09161 Cancer: overview
   05200 Pathways in cancer
    K10151  CCND2; G1/S-specific cyclin-D2
   05202 Transcriptional misregulation in cancer
    K10151  CCND2; G1/S-specific cyclin-D2
   05206 MicroRNAs in cancer
    K10151  CCND2; G1/S-specific cyclin-D2
   05203 Viral carcinogenesis
    K10151  CCND2; G1/S-specific cyclin-D2
  09172 Infectious disease: viral
   05166 Human T-cell leukemia virus 1 infection
    K10151  CCND2; G1/S-specific cyclin-D2
   05162 Measles
    K10151  CCND2; G1/S-specific cyclin-D2
   05169 Epstein-Barr virus infection
    K10151  CCND2; G1/S-specific cyclin-D2
   05165 Human papillomavirus infection
    K10151  CCND2; G1/S-specific cyclin-D2
Genes
HSA: 894(CCND2)
PTR: 747123(CCND2)
PPS: 100990850(CCND2)
GGO: 101139749(CCND2)
PON: 100457978(CCND2)
NLE: 100585770(CCND2)
MCC: 710379(CCND2)
MCF: 102119572(CCND2)
CSAB: 103218410(CCND2)
CATY: 105582988(CCND2)
PANU: 101004371(CCND2)
RRO: 104658979(CCND2)
RBB: 108536489(CCND2)
TFN: 117090678(CCND2)
PTEH: 111535839(CCND2)
CJC: 100390172(CCND2)
SBQ: 101049141(CCND2)
MMUR: 105881459(CCND2)
MMU: 12444(Ccnd2)
MCAL: 110296334(Ccnd2)
MPAH: 110315929(Ccnd2)
RNO: 64033(Ccnd2)
MCOC: 116099629(Ccnd2)
MUN: 110548628(Ccnd2)
CGE: 100771544(Ccnd2)
PLEU: 114701440(Ccnd2)
NGI: 103727547(Ccnd2)
HGL: 101721480(Ccnd2)
OCU: 100009036(CCND2)
TUP: 102479902(CCND2)
CFA: 611782(CCND2)
VVP: 112917379(CCND2)
VLG: 121479990(CCND2)
AML: 100471517(CCND2)
UMR: 103675743(CCND2)
UAH: 113258003(CCND2)
ORO: 101363193(CCND2)
ELK: 111159766
MPUF: 101684525(CCND2)
EJU: 114222473(CCND2)
MLX: 118025766(CCND2)
FCA: 101090950(CCND2)
PYU: 121021950(CCND2)
PTG: 102970259(CCND2)
PPAD: 109276198(CCND2)
AJU: 106965383(CCND2)
HHV: 120247732(CCND2)
BTA: 615414(CCND2)
BOM: 102272576(CCND2)
BIU: 109559745(CCND2)
BBUB: 102410004(CCND2)
CHX: 102180657(CCND2)
OAS: 100147799(CCND2)
ODA: 120857878(CCND2)
CCAD: 122424006(CCND2)
SSC: 397162(CCND2)
CFR: 116661359(CCND2)
CBAI: 105076506(CCND2)
CDK: 105091327(CCND2)
BACU: 103002964(CCND2)
LVE: 103077970(CCND2)
OOR: 101274693(CCND2)
DLE: 111176638(CCND2)
PCAD: 102981679(CCND2)
ECB: 100051150(CCND2)
EPZ: 103567717(CCND2)
EAI: 106831500(CCND2)
MYB: 102254218(CCND2)
MYD: 102755701(CCND2)
MMYO: 118650032(CCND2)
MNA: 107538904(CCND2)
HAI: 109392488(CCND2)
DRO: 112312821(CCND2)
SHON: 118999952(CCND2)
AJM: 119054859(CCND2)
MMF: 118624468(CCND2)
PALE: 102892640(CCND2)
PGIG: 120607308(CCND2)
RAY: 107513450(CCND2)
MJV: 108403976(CCND2)
TOD: 119247816(CCND2)
LAV: 100668070(CCND2)
TMU: 101351510
MDO: 100016259(CCND2)
SHR: 100915359(CCND2)
PCW: 110218698(CCND2)
OAA: 100088940(CCND2)
GGA: 374047(CCND2)
PCOC: 116237231(CCND2)
MGP: 104909362
CJO: 107318017(CCND2)
NMEL: 110390646(CCND2)
APLA: 101802600(CCND2)
ACYG: 106046294(CCND2)
TGU: 100224096(CCND2)
LSR: 110479030(CCND2)
SCAN: 103819603(CCND2)
PMOA: 120501661(CCND2)
GFR: 102034688(CCND2)
FAB: 101818224(CCND2)
PHI: 102114518(CCND2)
PMAJ: 107204709(CCND2)
CCAE: 111930045(CCND2)
CCW: 104696177(CCND2)
ETL: 114067087(CCND2)
FPG: 101920354(CCND2)
FCH: 102053549(CCND2)
CLV: 102093196(CCND2)
EGZ: 104124210(CCND2)
NNI: 104021822(CCND2)
PADL: 103917223(CCND2)
AAM: 106489562(CCND2)
NPD: 112953186(CCND2)
AMJ: 102564576(CCND2)
CPOO: 109316274(CCND2)
GGN: 109296569(CCND2)
PSS: 102462674(CCND2)
CMY: 102931445(CCND2)
TST: 117884539(CCND2)
CABI: 116820266(CCND2)
GJA: 107110411(CCND2)
XLA: 373667(ccnd2.L) 734882(ccnd2.S)
XTR: 100038071(ccnd2)
NPR: 108788361(CCND2)
DRE: 565038(ccnd2b) 799608(ccnd2a)
IPU: 100528326(ccnd2) 108279704(CCND2)
AMEX: 103031397(ccnd2) 111193357
ELY: 117249418 117261646(ccnd2a) 117268238(ccndx)
PLEP: 121949734(ccnd2a) 121957267(ccndx) 121961335
SLUC: 116053011(ccnd2a) 116060121 116063945(ccndx)
ECRA: 117938769 117948450(ccnd2a) 117957594(ccndx)
GAT: 120808903(ccnd2a) 120812517 120817973 120827676(ccndx)
MSAM: 119894029(ccnd2a) 119908399(ccndx) 119918426(ccnd2b)
CUD: 121505712 121515215(ccnd2a) 121529580(ccndx)
OAU: 116328674(ccndx) 116334728(ccnd2b) 116336265(ccnd2a)
OML: 112146031(ccndx) 112152245(ccnd2a) 112154304
CTUL: 119789178(ccnd2a) 119789997(ccndx) 119793178(ccnd2b)
KMR: 108233174 108237544(ccnd2a) 108237745(ccndx)
XGL: 120784119(ccndx) 120792847(ccnd2a) 120802400
AANG: 118210840(ccnd3) 118231828(ccnd2a)
LOC: 102684393(ccnd3) 102696519(ccnd2)
LCM: 102345953 102351286(CCND2)
CMK: 103182468(ccnd3) 103185578(ccnd2)
RTP: 109931888
BFO: 118406671
CIN: 100186373
SCLV: 120330681
SKO: 100303589(ccnd)
DME: Dmel_CG9096(CycD)
DER: 6550709
DSE: 6620005
DSI: Dsimw501_GD15773(Dsim_GD15773)
DSR: 110181715
DPE: 6603470
DMN: 117186171
DWI: 6652925
DGR: 6564908
DHE: 111596963
CCAT: 101462596
LCQ: 111677893
ACOZ: 120955026
AARA: 120901308
AME: 413183
BIM: 100744328
BTER: 100642333
CCAL: 108623408
OBB: 114875760
MGEN: 117224187
NMEA: 116427653
CGIG: 122396587
SOC: 105196203
MPHA: 105830325
AEC: 105149790
ACEP: 105619259
PBAR: 105427311
VEM: 105565318
HST: 105191023
DQU: 106748961
CFO: 105248357
FEX: 115235440
LHU: 105676942
PGC: 109855101
OBO: 105284703
PCF: 106790317
NVI: 100117434(cycD)
CSOL: 105362588
MDL: 103571676
DPA: 109541632
AGB: 108911534
LDC: 111502204
APLN: 108741430
BMOR: 100862781(cycD)
BMAN: 114245331
MSEX: 115448885
BANY: 112052468
PMAC: 106708805
PPOT: 106100515
PXU: 106123326
PRAP: 110996554
ZCE: 119833216
HAW: 110372374
TNL: 113508375
PXY: 105385267
DNX: 107168411
BTAB: 109039503
CLEC: 106666256
FCD: 110851356
DMK: 116919205
HAME: 121870865
VDE: 111249597
VJA: 111273965
DPTE: 113798117
CSCU: 111630486
PTEP: 107457517
SDM: 118185792
CEL: CELE_Y38F1A.5(cyd-1)
CBR: CBG02768(Cbr-cyd-1)
PCAN: 112566123
BGT: 106059492
GAE: 121372500
CRG: 105330764
MYI: 110454764
PMAX: 117327319
OBI: 106878898
LAK: 106173892
EGL: EGR_02547
NVE: 5500914
EPA: 110247806
ATEN: 116305033
ADF: 107334967
AMIL: 114962504
PDAM: 113677260
SPIS: 111345418
DGT: 114520980
HMG: 100198325
PVY: 116138490
AHF: 112782532
 » show all
Reference
PMID:1386336
  Authors
Xiong Y, Menninger J, Beach D, Ward DC
  Title
Molecular cloning and chromosomal mapping of CCND genes encoding human D-type cyclins.
  Journal
Genomics 13:575-84 (1992)
DOI:10.1016/0888-7543(92)90127-E
  Sequence
[hsa:894]
Reference
PMID:9178893
  Authors
Sweeney KJ, Sarcevic B, Sutherland RL, Musgrove EA
  Title
Cyclin D2 activates Cdk2 in preference to Cdk4 in human breast epithelial cells.
  Journal
Oncogene 14:1329-40 (1997)
DOI:10.1038/sj.onc.1200951
  Sequence
[hsa:894]
Reference
  Authors
Jena N, Deng M, Sicinska E, Sicinski P, Daley GQ
  Title
Critical role for cyclin D2 in BCR/ABL-induced proliferation of hematopoietic cells.
  Journal
Cancer Res 62:535-41 (2002)
  Sequence
[mmu:12444]
LinkDB

KEGG   ORTHOLOGY: K10152
Entry
K10152                      KO                                     

Symbol
CCND3
Name
G1/S-specific cyclin-D3
Pathway
map04110  Cell cycle
map04115  p53 signaling pathway
map04151  PI3K-Akt signaling pathway
map04218  Cellular senescence
map04310  Wnt signaling pathway
map04390  Hippo signaling pathway
map04510  Focal adhesion
map04630  JAK-STAT signaling pathway
map05162  Measles
map05164  Influenza A
map05165  Human papillomavirus infection
map05166  Human T-cell leukemia virus 1 infection
map05169  Epstein-Barr virus infection
map05200  Pathways in cancer
map05203  Viral carcinogenesis
map05207  Chemical carcinogenesis - receptor activation
Disease
H00010  Multiple myeloma
Brite
KEGG Orthology (KO) [BR:ko00001]
 09130 Environmental Information Processing
  09132 Signal transduction
   04310 Wnt signaling pathway
    K10152  CCND3; G1/S-specific cyclin-D3
   04390 Hippo signaling pathway
    K10152  CCND3; G1/S-specific cyclin-D3
   04630 JAK-STAT signaling pathway
    K10152  CCND3; G1/S-specific cyclin-D3
   04151 PI3K-Akt signaling pathway
    K10152  CCND3; G1/S-specific cyclin-D3
 09140 Cellular Processes
  09143 Cell growth and death
   04110 Cell cycle
    K10152  CCND3; G1/S-specific cyclin-D3
   04115 p53 signaling pathway
    K10152  CCND3; G1/S-specific cyclin-D3
   04218 Cellular senescence
    K10152  CCND3; G1/S-specific cyclin-D3
  09144 Cellular community - eukaryotes
   04510 Focal adhesion
    K10152  CCND3; G1/S-specific cyclin-D3
 09160 Human Diseases
  09161 Cancer: overview
   05200 Pathways in cancer
    K10152  CCND3; G1/S-specific cyclin-D3
   05207 Chemical carcinogenesis - receptor activation
    K10152  CCND3; G1/S-specific cyclin-D3
   05203 Viral carcinogenesis
    K10152  CCND3; G1/S-specific cyclin-D3
  09172 Infectious disease: viral
   05166 Human T-cell leukemia virus 1 infection
    K10152  CCND3; G1/S-specific cyclin-D3
   05164 Influenza A
    K10152  CCND3; G1/S-specific cyclin-D3
   05162 Measles
    K10152  CCND3; G1/S-specific cyclin-D3
   05169 Epstein-Barr virus infection
    K10152  CCND3; G1/S-specific cyclin-D3
   05165 Human papillomavirus infection
    K10152  CCND3; G1/S-specific cyclin-D3
Genes
HSA: 896(CCND3)
PTR: 462689(CCND3)
PPS: 100972595(CCND3)
GGO: 101130628(CCND3)
PON: 100452570(CCND3)
NLE: 100580170(CCND3)
MCC: 695215(CCND3)
MCF: 101865999(CCND3)
CSAB: 103221504(CCND3)
CATY: 105591815(CCND3)
PANU: 100137215(CCND3)
RRO: 104667309(CCND3)
RBB: 108533501(CCND3)
TFN: 117087209(CCND3)
PTEH: 111543039(CCND3)
CJC: 100408249(CCND3)
SBQ: 101047749(CCND3)
MMUR: 105875858(CCND3)
MMU: 12445(Ccnd3)
MCAL: 110312516(Ccnd3)
MPAH: 110335402(Ccnd3)
RNO: 25193(Ccnd3)
MCOC: 116075067(Ccnd3)
MUN: 110550225(Ccnd3)
CGE: 100766025(Ccnd3)
PLEU: 114705331(Ccnd3)
NGI: 103725891(Ccnd3)
HGL: 101708062(Ccnd3)
CCAN: 109682157(Ccnd3)
OCU: 100009038(CCND3)
TUP: 102499577(CCND3)
CFA: 608847(CCND3)
VVP: 112913983(CCND3)
VLG: 121499073(CCND3)
AML: 100479467(CCND3)
UMR: 103664092(CCND3)
UAH: 113261302(CCND3)
ORO: 101372891(CCND3)
ELK: 111147855
MPUF: 101689940(CCND3)
EJU: 114204469(CCND3)
MLX: 118001139(CCND3)
FCA: 101101311(CCND3)
PYU: 121029442(CCND3)
PTG: 102970915(CCND3)
PPAD: 109271613(CCND3)
AJU: 106974052(CCND3)
HHV: 120238692(CCND3)
BTA: 540547(CCND3)
BOM: 102268077(CCND3)
BIU: 109577151(CCND3)
BBUB: 102412107(CCND3)
CHX: 102190470(CCND3)
OAS: 100147798(CCND3)
ODA: 120870130(CCND3)
CCAD: 122429373(CCND3)
SSC: 780426(CCND3)
CFR: 102524562(CCND3)
CBAI: 105083774(CCND3)
CDK: 105086756(CCND3)
BACU: 103007761(CCND3)
LVE: 103072491(CCND3)
OOR: 101274576(CCND3)
DLE: 111178811(CCND3)
PCAD: 102987349(CCND3)
ECB: 100066590(CCND3)
EPZ: 103563494(CCND3)
EAI: 106824516(CCND3)
MYB: 102252389(CCND3)
MYD: 102756923(CCND3)
MMYO: 118660354(CCND3)
MNA: 107536896(CCND3)
HAI: 109382891(CCND3)
DRO: 112302074(CCND3)
SHON: 118991404(CCND3)
AJM: 119056484(CCND3)
MMF: 118621102(CCND3)
PALE: 102881884(CCND3)
PGIG: 120596338(CCND3)
RAY: 107501938(CCND3)
MJV: 108405335(CCND3)
TOD: 119252455(CCND3)
LAV: 100668683(CCND3)
TMU: 101351688
MDO: 100027538(CCND3)
SHR: 100921166(CCND3)
PCW: 110203289(CCND3)
OAA: 100088334(CCND3)
GGA: 419928(CCND3)
PCOC: 116236965(CCND3)
MGP: 100546832(CCND3)
CJO: 107324823(CCND3)
NMEL: 110388224(CCND3)
APLA: 101790685(CCND3)
ACYG: 106045863(CCND3)
TGU: 100218837(CCND3)
LSR: 110477163(CCND3)
SCAN: 115484353(CCND3)
PMOA: 120495869(CCND3)
GFR: 102033692(CCND3)
FAB: 101819978(CCND3)
PHI: 102106455(CCND3)
PMAJ: 107214873
CCAE: 111939904(CCND3)
CCW: 104692524(CCND3)
FPG: 101913539(CCND3)
FCH: 102059828(CCND3)
CLV: 102090134(CCND3)
EGZ: 104125735(CCND3)
NNI: 104013148(CCND3)
ACUN: 113488829(CCND3)
PADL: 103919864(CCND3)
AAM: 106483949(CCND3)
NPD: 112959195(CCND3)
ASN: 102386423(CCND3)
AMJ: 102560290(CCND3)
CPOO: 109317772(CCND3)
GGN: 109295394(CCND3)
PSS: 102445982(CCND3)
CMY: 102940098(CCND3)
CPIC: 101940970(CCND3)
TST: 117875833(CCND3)
CABI: 116827931(CCND3)
ACS: 100566165(ccnd3)
PVT: 110078878 110080664(CCND3)
PBI: 103060947(CCND3)
PMUR: 107293964(CCND3)
TSR: 106540193(CCND3)
PGUT: 117663931(CCND3)
PMUA: 114599266(CCND3)
ZVI: 118088329(CCND3)
GJA: 107119188(CCND3)
DRE: 449996(ccnd3)
SRX: 107723118
SANH: 107656907
SGH: 107572366
CCAR: 109088524
IPU: 108281084(ccnd3)
PHYP: 113539684(ccnd3)
AMEX: 103045792(ccnd3)
LCO: 104927998(ccnd3)
NCC: 104957029
CGOB: 115008042
ELY: 117257102(ccnd3)
PLEP: 121956400(ccnd3)
SLUC: 116041604(ccnd3)
ECRA: 117943266(ccnd3)
PFLV: 114553865
GAT: 120835040(ccnd3)
MSAM: 119886218(ccnd3)
CUD: 121507399(ccnd3)
MZE: 101472513(ccnd3)
ONL: 100690263
OAU: 116333801(ccnd3)
OLA: 101165722
OML: 112144604(ccnd3)
XMA: 102221373
XCO: 114136140
XHE: 116710801
PRET: 103465178(ccnd3)
CVG: 107085628(ccnd3)
CTUL: 119779972(ccnd3)
NFU: 107385769(ccnd3)
KMR: 108235802(ccnd3)
ALIM: 106516142(ccnd3)
AOCE: 111574366
CSEM: 103385889(ccnd3)
POV: 109629233(ccnd3)
LCF: 108886479(ccnd3)
SDU: 111222077
SLAL: 111660864(ccnd3)
XGL: 120807092(ccnd3)
HCQ: 109522291
BPEC: 110168781
MALB: 109964433(ccnd3)
SASA: 106583090
OTW: 112254562
OMY: 110528077(ccnd3)
SALP: 111970058
SNH: 120065733
ELS: 105017123(ccnd3)
PKI: 111852988(ccnd3)
ACER: 107995343
BBIF: 117210569
CCIN: 107268510
ATD: 109601133
AGB: 108909684
APLN: 108738019
BMOR: 101738852
BMAN: 114241730
MSEX: 115445851
BANY: 112054501
PMAC: 106707770
PPOT: 106103384
PXU: 106123434
PRAP: 110992868
ZCE: 119833186
HAW: 110378432
TNL: 113508047
BTAB: 109034725
DCI: 103518509
HHAL: 106691080
DMK: 116930044
VDE: 111245317
VJA: 111271524
CSCU: 111622028
PTEP: 107448152
SDM: 118199978
TSP: Tsp_06217
 » show all
Reference
  Authors
Liu W, Sun M, Jiang J, Shen X, Sun Q, Liu W, Shen H, Gu J
  Title
Cyclin D3 interacts with human activating transcription factor 5 and potentiates its transcription activity.
  Journal
Biochem Biophys Res Commun 321:954-60 (2004)
DOI:10.1016/j.bbrc.2004.07.053
  Sequence
[hsa:896]
Reference
PMID:1383201
  Authors
Motokura T, Keyomarsi K, Kronenberg HM, Arnold A
  Title
Cloning and characterization of human cyclin D3, a cDNA closely related in sequence to the PRAD1/cyclin D1 proto-oncogene.
  Journal
J Biol Chem 267:20412-5 (1992)
  Sequence
[hsa:896]
LinkDB

DBGET integrated database retrieval system